Left ventricular non-compaction cardiomyopathy is a genetic disorder characterized by the presence of two myocardial layers with numerous prominent trabeculations and deep inter-trabecular recesses that communicate with the ventricular cavity. The diagnosis is often challenging because excessive trabeculations may also be a normal finding in performance athletes and black people.
Introduction
Left ventricular non-compaction (LVNC) or 'spongy myocardium' is a congenital disorder characterized by the presence of a thin epicardial layer and an excessively trabeculated endocardial layer. This particular spongious aspect of the myocardium was first described more than eight decades ago in association with aortic atresia and coronary-to-chamber fistula during the autopsy of a newborn with complex congenital abnormalities (1) . The introduction of two-dimensional echocardiography facilitated the evaluation of left ventricle (LV) anatomy and continuously increased the number of cases diagnosed. In 1984 Engberding described the presence of 'sinusoids' within the LV, but it was not until 1990 that the first diagnostic echocardiographic criteria of LVNC were proposed and terminology was established (2, 3) .
Despite current developments in cardiac imaging
and genetic diagnostic techniques, it is yet controversial whether left ventricular non-compaction cardiomyopathy is a distinct cardiomyopathy or a morphologic feature shared by different types of cardiomyopathy (4) . Recent data, for example, have found that a significant proportion of asymptomatic individuals free from cardiovascular disease met all currently used magnetic resonance imaging (MRI) diagnostic criteria for LVNC, suggesting that the condition is an anatomical phenotype rather than a distinct cardiomyopathy (5) . To add to the controversy, non-compacted myocardium has been categorized as unclassified cardiomyopathy by the European Society of Cardiology (ESC) in the recently published report on the definition and classification of cardiomyopathies (6), whereas the American Heart Association (AHA) classifies it as a primary genetic cardiomyopathy (7) (Figure 1 ). 
Discussion

Prevalence
The prevalence of LVNC in the general population remains unknown, although in echocardiographic series it is reported around 0.14-1.3%. Isolated ventricular noncompaction has an incidence of 0.01-0.26% in observational studies (8, 9) . In a pediatric population with any type of primary cardiomyopathy, LVNC was diagnosed in 9.2%, being the most frequent form after dilated and hypertrophic cardiomyopathy (10) . Left ventricular non-compaction in children is often associated with anatomical abnormalities such as septal or atrial defects, congenital aortic stenosis, and aortic coarctation, although studies have failed to demonstrate any direct relation among these conditions. Furthermore, non-compacted myocardium has been found in patients with neuromuscular diseases such as Becker muscular dystrophy, Friedrich ataxia, myotonic dystrophy, or mitochondrial diseases. 
Imaging and Diagnosis
A multimodal diagnostic approach is the current recommendation for LVNC diagnosis.
Echocardiography, although dependent on the echocardiographer's skills and the echocardiographic window, remains the primary diagnostic method. Other imaging methods such as cardiac MRI can diagnose the pathology, when echocardiographic examination is suboptimal.
Echocardiographic diagnosis criteria
Transthoracic bidimensional echocardiography (2D- 
Other diagnostic imaging
Computed tomography (CT) is an alternative method of diagnosing LVNC if the echocardiogram is non-diagnostic or unavailable (36) . Positron emission tomography (PET), which quantitatively evaluates myocardial blood flow and coronary flow reserve, may be used to assess microcirculatory dysfunction ultimately responsible for the wall motion abnormalities (37).
Differential diagnosis
As there is no diagnostic gold standard, LVNC is 
